FDA to Host Public Meeting on Clinical Trial Data Monitoring Committees

Summary

The US Food and Drug Administration (FDA) will hold a public meeting to discuss its draft guidance on the establishment and operation of clinical trial data monitoring committees, which oversee the safety and efficacy of clinical trials.